Stockreport

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata [Yahoo! Finance]

Equillium, Inc.  (EQ) 
Last equillium, inc. earnings: 3/26 04:07 pm Check Earnings Report
PDF EQ101 was well tolerated in subjects with alopecia areata with no serious adverse events reported Data supports advancing EQ101 development in alopecia areata to incl [Read more]